Beyond TIMI 3 Flow CTFC < 14 CTFC > 40 0.0% (n=41) (n = 18/640) (n =35/563) 2.8% p= 0.003 “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < 40 6.2% % Risk of In Hospital.

Slides:



Advertisements
Similar presentations
The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.
Advertisements

Early Impaired Myocardial Perfusion is Associated with Larger SPECT Infarct Size Patients with a closed myocardium (TMPG 0/1) and patients without complete.
Protection Devices in PCI-Treatment of Myocardial Infarction for Salvage of Endangered Myocardium Study Presented at American College of Cardiology Scientific.
Unstable Angina: Embolism Can Occur Prior to PCI Thrombus in proximal RCA Stain of muscle before injection begins: TIMI Myocardial perfusion grade 1 CM.
Distal Protection: PRIDE, CAPTIVE Symbiot III, AiMI Dr James Cotton MD MRCP Heart and Lung Centre Wolverhampton.
on behalf of the TOTAL Investigators
Intracoronary Serotonin and Endothelin Release After PCI / Stenting Taylor AJ. Am Heart J Aug;148(2): e10 Leosco et al, AJC 1999;84:
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
The AiMI Trial Arshad Ali, MD, David Cox, MD, Nabil Dib, MD, Bruce Brodie, MD, Daniel Berman, MD, Navin Gupta, MD, Kevin Browne, MD, Robert Iwaoka, MD,
GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
Results of CRYSTAL AMI: A Pilot Trial Before INFUSE AMI, the Concept and Evolution in Thrombus Management Saihari Sadanandan, MD, FACC, FASE, Dip. CBNC,
Clinical Trial Results. org C. Michael Gibson, M.S., M.D. Director TIMI Data Coordinating Center Invasive Cardiologist Beth Israel Deaconess Medical Center.
Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University,
ATTEMPT study: pooled-Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data CLINICAL TRIAL UPDATE III ESC.
Is PCI necessary for AMI related artery with TIMI 3 flow ? Donghoon Choi Yonsei Cardiovascular Center Yonsei University College of Medicine.
Effect of Intracoronary Streptokinase Administered Immediately after Primary PCI on Left Ventricular Infarct Size, Volume and Function (J Am Coll Cardiol.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
The Impact of Thrombus Aspiration on 1-year Mortality in Primary PCI for ST-Elevation Myocardial Infarction, ACSIS 2010 Experience Mady Moriel, Shlomi.
The “Code White” Team of Dr. William Ganz: 1979 Goal of IC SK Before PCI: Get the artery open.
TIMI 14 Antman et al. Circ 99: 2720,1999 Phases of Trial ControlInvestigational Accel tPA Accel tPA Accel tPA rPA ( U) rPA ( U) No lytic Abx.
The 90 Minute Wall: 60% Rates of TIMI Grade 3 Flow % TIMI 3 Flow.
Relationship of Ultrasound Plaque Characteristics to TMPG Following Intracoronary Stenting ↓ TMPG Post PCINo Δ or ↑ TMPGp-value Pre-PCI Plaque Area12.4.
Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #2: Drugs (in this case IC.
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
LESSON 1 LESSON 1 Establishment of:
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
For OMA distribution only. Trademarks may be registered and are the property of their respective owners. © 2013 Medtronic, Inc. All rights reserved. UC ML.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Trial Vignettes 1-3 Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Trust.
PROTECT: What Have We Learned Lesson 2: TMPG is associated with clinical and biomarker outcomes following PCI.
Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet and Anti-Thrombotic.
Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.
The MASTER Trial A Prospective, Randomized, Multicenter Evaluation of a PET Micronet Mesh Covered Stent (MGuard) in STEMI Sigmund Silber, MD, PhD FESC,
Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the.
Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli M.D., Francesco.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Intra Coronary AdjunctivE Tenecteplase During Primary PCI for STEMI:
Circ Cardiovasc Interv
No Reflow Reflow P value Arrhythmia 40% 18% Lecture Notes
European Society of Cardiology 2003
Nat. Rev. Cardiol. doi: /nrcardio
PROTECT – TIMI 30 Trial Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet.
Published in the European Heart Journal
In STEMI Complete Reperfusion (TFG 3, TMPG 3, ST Res  70%) is Associated with a Greater Percent of Receptors Occupied by Integrilin 52.0% % Pts With Complete.
Myocardial Staining (TMPG 1)  Post-Stent in AMI
52.0% Complete Resolution TFG 3 TMPG 3 ST Resolution  70% p=0.006
Secondary Efficacy Endpoints
Figure 4 Observational studies on multiple treatment strategies
TIMI Myocardial Perfusion (TMP) Grades Dye strongly persistent
Role of Stenting in Acute MI: PAMI Stent Pilot Trial
Dye strongly persistent
Mechanical Prevention of Distal Embolization During Primary Angioplasty: Safety, Feasibility, and Impact on Myocardial Reperfusion Ugo Limbruno, MD, PhD;
Maintenance of Long-Term Clinical Benefit with
DEScover: One-Year Clinical Results
A New Angiographic Risk Score in Facilitated PCI
Dye strongly persistent
Association of Troponin Elevation with Risk of Mortality in Acute Coronary Syndromes Mortality at 42 Days  % A study by Antman and.
European Heart Journal Advance Access
MRI Hyperenhancement is Associated with Myonecrosis Following PCI
Evolution of Myocardial Blush after MI
GUSTO 1 Trial 41,000 patients enrolled, landmark study
ESPRIT INTEGRITI TACTICS Rate of Increase in DSA
Dye strongly persistent
Presentation transcript:

Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital Mortality Gibson, Circulation 1999; 99: Hyperemic Flow Reproducibility: r = 0.97 between readers Accuracy: r=0.88 vs Doppler velocity Reproducibility: r = 0.97 between readers Accuracy: r=0.88 vs Doppler velocity

TIMI Myocardial Perfusion (TMP) Grades 6.2% 4.4% 2.0% n = 203 n = 46 n = 434 TMP Grade 3 p = 0.05 Mortality (%) n = % Gibson et al, Circulation 2000 Normal ground glass appearance of blush Dye mildly persistent at end of washout Normal ground glass appearance of blush Dye mildly persistent at end of washout Dye strongly persistent at end of washout Gone by next injection Dye strongly persistent at end of washout Gone by next injection Stain present Blush persists on next injection Stain present Blush persists on next injection No or minimal blush TMP Grade 2 TMP Grade 1 TMP Grade 0

Not All TIMI Grade 3 Flow is Created Equally: Myocardial Perfusion Grade 3 Myocardial Perfusion Grade 3 Myocardial Perfusion Grade 2 Myocardial Perfusion Grade 2 Myocardial Perfusion Grades 0/1 Myocardial Perfusion Grades 0/1 N = 136 N = 34 N = % 2.9% 5.4% % Mortality P = Gibson CM, et al. Circulation. 2000;101: Among Patients. With Successful Lysis, There is a 7 Fold Range in Mortality

TIMI 10 B: Independent Predictors of 2 Year Mortality TIMI Grade 3 FlowRR 0.61, p=0.047 TIMI Myocardial BlushRR 0.50, p = TIMI Grade 3 FlowRR 0.61, p=0.047 TIMI Myocardial BlushRR 0.50, p = In a MV model correcting for : Performance of PCI Age Gender Pulse Anterior MI In a MV model correcting for : Performance of PCI Age Gender Pulse Anterior MI Pre-PCI Epicardial and Myocardial Flow Are Independently Associated with 2 Year Mortality Gibson et al, Circulation 2002

p< /1 2 n=690 n=55 n=32 0/1 n=236 2 n=393 3 n=148 TIMI Flow GradesMyocardial Blush Grades Survival Time (days) p< van ‘t Hof AWJet al. Circulation 1998; 97: Myocardial Reperfusion Score Zwolle Myocardial Blush Grades (n=777)

A Comparison of TMPP and Zwolle System TIMI Epicardial Flow Grade TIMI Myocardial Perfusion Grade Zwolle System Grade 0No flow Grade 1Penetrates but does not perfuse Dye penetrates but is stuck in muscle Very Pale Grade 2Slow flow in artery Slow flow in muscle Less Pale Grade 3Normal flow in artery Normal flow in muscle

A Comparison of TMPG and Zwolle System TIMI Myocardial Perfusion Grade Zwolle System Grade 0No flow Grade 1Dye penetrates but is stuck in muscle Very Pale Grade 2Slow flow in muscle Less Pale Grade 3Normal flow in muscle

A Comparison of TMPP and Zwolle System TIMI Myocardial Perfusion Grade Zwolle System Grade 0 or 1No flow = Grade 2 or 3Normal or near normal =

Myocardial Perfusion After Primary PCI is Strongest Predictor of Mortality /1 n=236 2 n=393 3 n=148 Myocardial Blush Grades Time (days) /1 100 Cumulative Survival (%) Final Blush Score (patients with final TIMI grade 3 flow) Blush 1-Year Mortality 3 2 0/1 6.8% 13.2% 18.3% P=0.004 RR*95% CIP MBG 0 and 1 vs 2 and to MVD 2 and 3 vs to LAD vs non-LAD MI to TIMI flow before: 0 to 2 vs to Independent Angiographic Variables as Risk Factors of Long-Term Mortality in Patients With TIMI Grade 3 flow After Angioplasty MBG 0/1 (n=100) MBG 2 (n=74) MBG 3 (n=79)P Death at 30 days 26.0%9.9%3.9%<0.001 Death at 1 year 35.1%13.4%9.4%<0.001 Death during F/U 39.0%18.3%12.4%<0.001 Relation of Myocardial Perfusion Grade to Mortality  2 of 3 pts have a closed muscle after 1 0 PCI  Mortality goes up 3 fold  2 of 3 pts have a closed muscle after 1 0 PCI  Mortality goes up 3 fold Stone GW, et al. J Am Coll Cardiol. 2002;39: Haagar PK, et al. J Am Coll Cardiol. 2003;41: Henriques JP, et al. Circulation. 2003;107: van ‘t Hof AWJet al. Circulation 1998; 97:

Peak Myocardial Brightness, Circumference and Circumference Growth in Culprit and Non-culprit Arteries in Acute MI and in Normal Patients p < Normal Non-culprit AMI DSA Peak Gray Scale Culprit AMI p = NS p < p = NS p < (cm/sec) p = 0.02 Peak Circumference Peak Circumference Growth (cm) n=65 n=290 n=161 n=88 n=377 n=187 n=85 n=305 n=182 Murphy SA, Am J Cardiol 2003

Early Impaired Myocardial Perfusion is Associated with Larger SPECT Infarct Size Patients with a closed myocardium (TMPG 0/1) and patients without complete ST resolution (<70%) had larger infarcts. In a multivariate model, both impaired TMPG and incomplete ST resolution were independently associated with larger infarct size Patients with a closed myocardium (TMPG 0/1) and patients without complete ST resolution (<70%) had larger infarcts. In a multivariate model, both impaired TMPG and incomplete ST resolution were independently associated with larger infarct size n=209 n=111 p<0.001 Median = 13 TMPG ST Resolution p=0.004 Res <70% Res >70% TMPG 0/1 TMPG 2/3 n=108 n=113 Median = 7 Median = 6 Median = 14 % SPECT Infarct Size Circulation 2002

Reduction in Plaque Volume (mm 3 ) TMPG 3 Mortality 0% TMPG 3 Mortality 0% TMPG 0-2 Mortality 22% TMPG 0-2 Mortality 22% P=0.077 for mortality P=0.077 for mortality P= Greater Reduction in Plaque Area on IVUS is Associated with Impaired TIMI Myocardial Perfusion Grades (TMPG 0-2) in STEMI Kotani J,Mintz GS,Pregowski J et al for Wash Hosp Ctr, Am J Cardiol 2003; 92:728–732. N=17 N=18 Multivariate analysis indicated that the strongest predictor of a closed myocardium (TMPG 0-2) after primary PCI was a greater reduction in plaque volume on IVUS

FilterWire-Ex as an Adjunct to Primary PCI Corrected TIMI Frame Count p=0.005 Corrected TIMI Frame Count p=0.005 TIMI Frame Count Myocardial Blush Grade 3 p=0.006 Myocardial Blush Grade 3 p=0.006 Circulation 2003; 108: Design: Compared use of the FilterWire-Ex (FW) distal embolic protection device as an adjunct to primary PCI (n=53) vs matched control (n=53) in patients with acute MI. Results FW successfully positioned in 89% patients without complication FW use remained only independent predictor of ST-segment resolution (OR 0.18, 95% CI , p=0.003) and myocardial blush grade 3 (OR 0.33, 95% CI , p=0.01) All 13 filters that underwent histological analysis contained multiple embolic debris No difference in 30 day MACE rates (5% for FW vs 11% for controls, p=0.488) Design: Compared use of the FilterWire-Ex (FW) distal embolic protection device as an adjunct to primary PCI (n=53) vs matched control (n=53) in patients with acute MI. Results FW successfully positioned in 89% patients without complication FW use remained only independent predictor of ST-segment resolution (OR 0.18, 95% CI , p=0.003) and myocardial blush grade 3 (OR 0.33, 95% CI , p=0.01) All 13 filters that underwent histological analysis contained multiple embolic debris No difference in 30 day MACE rates (5% for FW vs 11% for controls, p=0.488) Filter Wire Control % ST-segment Resolution p=0.006 ST-segment Resolution p=0.006 %

Coronary Flow Reserve Antithrombin + Eptifibatide Antithrombin + Eptifibatide N=27 N=16 P=0.02 Gray per sec P=0.05 N=27 N=18 Coronary Flow Reserve Rate of Increase in DSA Brightness (Gray /sec) Rate of Increase in DSA Brightness (Gray /sec) Circumference (cm) N=24 N= P=0.18 Rate of Growth in Blush Circumference (cm / sec) Rate of Growth in Blush Circumference (cm / sec) ESPRIT Substudy: Results All Patients Have TIMI Grade 3 Flow at Completion of Stenting & Antithrombin Treatment Antithrombin + Eptifibatide Antithrombin + Eptifibatide Antithrombin + Eptifibatide Antithrombin + Eptifibatide Gibson CM et al, Am J Cardiol 2001;87(11):

TMPG and Maximum CK-MB 24 Hours Post-stent Maximum CK-MB >2x ULN (%) 41.2% p = /2414/34 4.2% All Patients Have TIMI 3 Flow at Completion of Stenting Gibson CM et al, Am Heart J Jan;143(1): Stain Slow Pale Normal

TMPG Post-stent and Composite Events by 48 Hrs & 1 Yr Composite Event (%) 1 Year Death, MI, Urgent TVR p = % 4.2% 1/24 11/34 All Patients Have TIMI 3 Flow at Completion of Stenting Stain Slow Pale Normal Gibson CM et al, Am Heart J Jan;143(1):

A Decline in TMPG after Stenting is Associated with Larger Infarct Sizes Ricciardi, Gibson et al, CCD 2004 All patients had normal epicardial TIMI Grade 3 Flow before PCI 12 of 14 patients had normal TMPG 3 before PCI Only 7 of 14 had normal TMPG 3 after PCI All patients had normal epicardial TIMI Grade 3 Flow before PCI 12 of 14 patients had normal TMPG 3 before PCI Only 7 of 14 had normal TMPG 3 after PCI CK-MB p=0.01 HE mass p=0.04 No Yes Decline in post-stent TMPG HE mass (gm) CK-MB (ng/dL) = = Ramondo et al,Catheter Cardiovasc Interv 2004;61:222–226.

Tn I (ng / mL) tn T (ng / mL) TMPG 0/1 TMPG 2/3 P=0.006 P=0.007 TMPG 2/3 TMPG 0/1 Peak [tnT] and [tnI] by TIMI Myocardial Perfusion Grade (TMPG) status Circulation 2002;106:

Troponin Elevations on Admission are Associated with Tissue Level Perfusion Following PCI: TACTICS TIMI 18 p=0.004 p=0.013 % TMPG 0/1 Circulation 2002;106:

Troponin T & Angiographic Findings % Stenosis % Vessel Occlusion % Normal TMPG 3 % Thrombus tnT + tnT - P=0.021 P= P=0.03 P=0.007 Even when epicardial TIMI flow grade and the presence of thrombus were adjusted for, the presence of a closed microvasculature was independently associated with tnT elevation in a multivariate model (O.R. 1.79, p=0.017). Circulation 2002

Event Free Survival is Associated with Tissue Level Perfusion in UA / Non Q Wave MI: TACTICS – TIMI 18 Circulation 2002;106: p=0.026 Days Event Free Survival TMPG 0/1 Pre & Post PCI TMPG 0/1 Pre & Post PCI TMPG 2/3 Pre or Post-PCI Stain Slow Pale Normal N = 253 % TMPG 3 P = “Upstream” Duration (> median) “Upstream” Duration (> median) Impaired tissue perfusion on diagnostic cath is associated with Tn + and adverse outcomes Earlier upstream initiation of GPIIbIIIa inhibition is associated with improved tisse perfusion om diagnostic cath Impaired tissue perfusion on diagnostic cath is associated with Tn + and adverse outcomes Earlier upstream initiation of GPIIbIIIa inhibition is associated with improved tisse perfusion om diagnostic cath Gibson CM, AHA 2001

Troponin Elevations on Admission are Associated with Tissue Level Perfusion Following PCI: TACTICS TIMI 18 p=0.004 p=0.013 % TMPG 0/1 Circulation 2002